Paul Rivard - 07 Jun 2023 Form 4 Insider Report for MyMD Pharmaceuticals, Inc. (TNFA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MYMD	Employee Stock Option (Right to Buy)	Award	$0	+150,000		$0.000000	150,000	07 Jun 2023	Common Stock	150,000	$1.66	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.